肿瘤的免疫细胞治疗

Immunocellular Therapy of Tumor

呼吸系统疾病特别是肺纤维化的免疫调控机制研究及干细胞治疗

Immune regulation mechanism of respiratory diseases, especially pulmonary fibrosis and stem cell therapy

同济大学附属东方医院大内科教秘

Secretary of Internal Medicine Department Faculty Working Office, East Hospital, Tongji University School of Medicine

中华医学会呼吸病学分会肺癌学组青年协作组委员

Youth Federation Member of Chinese Thoracic Society Lung Cancer Group

上海市医学会呼吸病学分会间质性肺病学组 秘书

Secretary of the Interstitial Lung Disease Group of the Respiratory Disease Branch of the Shanghai Medical Association

上海市医学会呼吸病学分会肺癌学组 委员

Member of the Lung Cancer Group of the Respiratory Disease Branch of the Shanghai Medical Association

中国抗癌协会会员

Member of China Anti Cancer Association

北京大学医学博士，现任同济大学附属东方医院大内科教秘，呼吸医学中心、肺癌中心副主任医师，间质性肺病亚专业学术带头人，曾荣获国家“优秀志愿者”称号、青年志愿者铜奖奖章，上海市优秀规培指导老师，优秀青年呼吸医师，东方医院“东方人物”等荣誉。

研究方向主要聚焦肿瘤的免疫细胞治疗，间质性肺疾病的免疫机制及干细胞治疗。主持在研及参与国家自然科学基金面上项目、北京科委专项、北京大学临床X专项、上海科创基金项目、免疫学国家重点实验室开放课题等各类基金8项，于Molecular Therapy、Acta Biomaterialia、ACS Applied Bio Materials、Autophagy等期刊主导及参与发表论文10余篇。主导及参与在研“肺癌介入免疫治疗”、“新型T细胞治疗肿瘤”、“纤维化肺疾病干细胞治疗”等临床试验多项。

欢迎国内外感兴趣的同学一起参与以上科学问题的探索研究，我们将根据不同的课题，选择与中国科学院、北京大学等一流的研究平台合作，共同进步！最后，再次感谢有缘人的关注，谢谢！

I graduated from Peking University with a doctor’s degree,and currently serving as the Teaching Secretary of the Department of Internal Medicine at Tongji University Affiliated Oriental Hospital, Deputy Chief Physician of the Respiratory Medicine Center and Lung Cancer Center, Academic Leader of the Interstitial Lung Disease Subspecialty, and recipient of the National “Outstanding Volunteer” title, the Youth Volunteer Bronze Medal, Shanghai Outstanding Resident Training Instructor, Outstanding Young Respiratory Physician, and Oriental Hospital “Oriental Figure” honors.

Our research direction mainly focuses on immunotherapy for tumors, the immune mechanisms of interstitial lung disease, and stem cell therapy. I have led or participated in eight research projects, including those funded by the National Natural Science Foundation of China, the Beijing Municipal Science and Technology Commission, Peking University Clinical X Project, the Shanghai Science and Technology Innovation Fund, and the State Key Laboratory of Immunology Open Project,With over ten published papers in journals such as Molecular Therapy, Acta Biomaterialia, ACS Applied Bio Materials, and Autophagy, also leading or participating in several ongoing clinical trials, including “Interventional Immunotherapy for Lung Cancer,” “Novel T-cell Therapy for Tumors,” and “Stem Cell Therapy for Fibrotic Lung Disease.”.

Welcome interested students at home and abroad to participate in the exploration and research of the above related scientific issues. Depending on the specific topic, we will choose to collaborate with top-tier research platforms such as the Chinese Academy of Sciences and Peking University to achieve mutual progress! Finally, thank you again for your attention!